2m 2m 2m 2m 2m 2m 2m
UROGEN PHARMA (URGN)
NASDAQ
$35.09+$0.09 (+0.27%)
Price as of Jun 23, 2026 3:18 PM EDT- $1.6BMarket Cap
- 144.69%1-Year Change
- BiotechnologyIndustry
UROGEN PHARMA (URGN)
$35.09+$0.09 (+0.27%)
Earnings Score
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -0 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 63.53% | ||
12-Month Momentum | 106.28% | ||
3-Month Risk Adjusted Momentum | 214.13% | ||
12-Month Risk Adjusted Momentum | 160.84% |
True Yield
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -15.36% |
Financial Health Score
Valuation | URGN | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 3 |